I think thats where it’s going
it used to be that stems were regenerative, ie they would grow to replace damaged tissue (ie cardiac, vertebral discs etc). Now it seems the use effect is primarily anti inflammatory, which may have some application but there are plenty of well studied, reliable and cheap anti inflammatories around.
hence Msb keep having to “adapt” their goals to fit the trial results, cos they don’t really know how stems work or what they do. They may get there eventually, maybe.
Cell Therapy News/Articles, page-12388
-
- There are more pages in this discussion • 5,931 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.37 |
Change
-0.085(5.84%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.43 | $1.37 | $4.120M | 2.955M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 23898 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 19858 | 21 |
View Market Depth
| Last trade - 14.41pm 16/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |